Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2014, Article ID 312193, 6 pages
http://dx.doi.org/10.1155/2014/312193
Clinical Study

Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer

1Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Markey Cancer Center, University of Kentucky, 800 Rose Street, Lexington, KY 40536-0293, USA
2Cancer Prevention and Control Program, Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0293, USA
3Department of Statistics, Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0293, USA

Received 13 May 2014; Revised 7 July 2014; Accepted 9 July 2014; Published 1 September 2014

Academic Editor: Peter E. Schwartz

Copyright © 2014 John Hoff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

John Hoff, Lauren Baldwin, Jason Lefringhouse, et al., “Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer,” Journal of Oncology, vol. 2014, Article ID 312193, 6 pages, 2014. https://doi.org/10.1155/2014/312193.